EUVIMEDEUVIMED entdecken
Crossref

Dapagliflozin: A new drug for treatment of type 2 diabetes mellitus

AmeyaA Hasamnis

Journal of Academy of Medical Sciences · 2012

DOI: 10.4103/2249-4855.104018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Academy of Medical Sciences, 2012. Verfasst von AmeyaA Hasamnis. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hasamnis, A. (2012). Dapagliflozin: A new drug for treatment of type 2 diabetes mellitus. Journal of Academy of Medical Sciences. https://doi.org/10.4103/2249-4855.104018

Vancouver

Hasamnis A. Dapagliflozin: A new drug for treatment of type 2 diabetes mellitus. Journal of Academy of Medical Sciences. 2012. doi:10.4103/2249-4855.104018

BibTeX
@article{Hasamnis2012,
  author = {Hasamnis, AmeyaA},
  title = {Dapagliflozin: A new drug for treatment of type 2 diabetes mellitus},
  journal = {Journal of Academy of Medical Sciences},
  year = {2012},
  doi = {10.4103/2249-4855.104018}
}
Kostenlos starten →